Nucleus Genomics' embryo selection product faces strong criticism

Nucleus Genomics, a genetic testing startup, has sparked outrage with its new "Nucleus Embryo" product, which claims to allow parents to select embryos based on traits like IQ and appearance. The announcement has been met with widespread criticism. The company, founded by Kian Sadeghi, already faced controversy for products claiming to predict complex traits. Nucleus Embryo uses "polygenic scores" to assess traits in IVF embryos, a practice that is not widely accepted by medical professionals. Critics, including investors, have expressed strong disapproval, citing ethical concerns and the unreliability of the technology. Nucleus partners with other companies to provide the embryo testing, but the concept has been widely condemned.